It has been reported that FGFR2 fusions occur with diverse fusion partners, especially in cholangiocarcinoma, and these genetic aberrations of FGFR2 induce cancer cell proliferation and tumorigenesis [32–35]. This evidence concerns the gene FGFR2 and cancer.